NEUWAY Pharma
PrivateLast Round
Convertible Debt
Jun 16, 2021
Total Funding Raised
$27.69M
Company Overview
NEUWAY Pharma is a biotechnology company developing therapies for the treatment of central nervous system (CNS) diseases based on its proprietary drug delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NEUWAY Pharma Comparables
Compare NEUWAY Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gate2Brain | 84% | |
| Lauren Sciences LLC | 84% | |
| Ossianix | 79% |
NEUWAY Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jun 16, 2021 | ||||
| Series A | Mar 1, 2018 | ||||
| Grant | Aug 1, 2015 | ||||
| Grant | Apr 1, 2014 |
NEUWAY Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Ministry of Education and Research | Grant |
| Life Science Inkubator | Series A |
| Wellington Partners | Series A |
| KfW Development Bank | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2021
Raised $10M in convertible debt.
- Mar 1, 2018
$11.3M round led by Wellington Partners
NEUWAY Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NEUWAY Pharma's valuation, stock price, and market status.
Is NEUWAY Pharma a public or private company?
NEUWAY Pharma is a private company.
What is the current stock price of NEUWAY Pharma?
NEUWAY Pharma is a private company with no public stock price. Caplight tracks NEUWAY Pharma's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is NEUWAY Pharma worth (valuation)?
Valuation information for NEUWAY Pharma is not publicly available.
Can I buy NEUWAY Pharma stock?
NEUWAY Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NEUWAY Pharma's last funding round?
NEUWAY Pharma's most recent funding round was Convertible Debt on June 16, 2021.
Who are the main investors in NEUWAY Pharma?
Key investors in NEUWAY Pharma include Wellington Partners.
Will NEUWAY Pharma IPO soon?
No public IPO plans have been announced for NEUWAY Pharma.
How can I track NEUWAY Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NEUWAY Pharma's secondary market activity and sign up for updates.